Related Experiment Video
Updated: Jan 15, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
The relationship between estrogen and renin angiotensin system components in the context of hypertension
Samira Choopani1,2, Mehdi Nematbakhsh3
1Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Estrogen, particularly estradiol, may protect against hypertension by influencing the renin-angiotensin system (RAS). This review explores how estrogen impacts RAS components, contributing to sex differences in blood pressure regulation.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Nephrology
Background:
- Hypertension is a major risk factor for cardiovascular diseases (CVD), stroke, and kidney disease.
- The renin-angiotensin system (RAS) critically regulates blood pressure (BP) and is implicated in hypertension development.
- Sex disparities in hypertension are observed, suggesting hormonal influences.
Purpose of the Study:
- To explore the relationship between estrogen and RAS components in hypertension.
- To understand how estradiol influences BP regulation through the RAS.
- To investigate the basis for sex differences in hypertension.
Main Methods:
- Literature review focusing on estrogen's effects on RAS.
- Analysis of studies examining estradiol's impact on BP regulation.
- Exploration of sex-based differences in hypertensive models.
Main Results:
- Estradiol may exert protective cardiovascular and renal effects.
- Estrogen influences RAS components, including substrates, enzymes, and receptors.
- These interactions contribute to sex disparities in hypertension.
Conclusions:
- Estrogen plays a role in modulating BP via the RAS.
- Understanding estrogen-RAS interactions is key to addressing sex differences in hypertension.
- Further research into these mechanisms could reveal novel therapeutic targets.
Abstract:
Hypertension is recognized as a significant risk factor for the development of cardiovascular diseases (CVD), stroke, and kidney diseases. Although hypertension is influenced by numerous factors, the renin-angiotensin system (RAS) is widely acknowledged as a critical regulator of normal blood pressure (BP) stability and a significant contributor to the development of hypertension. RAS has different peptides and receptors that exert their effects via two alternative and classical pathways. In females, estradiol exhibits protective effects on the cardiovascular and renal systems. It may modulate BP regulation via its influence on the RAS, affecting the levels of crucial substrates, enzymes, receptor expression, and protein production. Sex disparities in hypertension are apparent in various hypertensive animal models. This review explored the connection between estrogen and RAS components in the context of hypertension.
Related Concept Videos
Hormonal Regulation
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

